Epigenetic Therapeutic Targets Summit
Evvnt Promotion / evvnt
Archiv
13.07.2021 - 15.07.2021 Virtual
Time: 1:00 pm - 4:00 pm
Kongressthemen
Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.
The two-day program will enable you to:
Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
Returning for its second year, the virtual Epigenetic Therapeutic Targets Summit is the first-ever industry forum dedicated exclusively to the frontier of drug development in epigenetics.
The two-day program will enable you to:
Explore the full spectrum oncological and non-oncological applications of genetic regulation therapeutics that is being investigated to identify new unmet clinical needs that epigenetics could be central to treating.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/742339-3?pid=4832
Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more
Brochure: https://go.evvnt.com/742339-3?pid=4832
Speakers: Ellen Filvaroff, Executive Director in Translational Development, Bristol-Myers Squibb, Elisabetta Chiarparin, Director - Medicinal Chemistry, AstraZeneca and more
Anfragen und Anmeldung:
https://go.evvnt.com/742339-2?pid=4832
Herr Customer Service
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 1499.00 - USD 2498.00
USD 1499.00 - USD 2498.00
Teilnehmer erwartet
1000
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
